NCT02426970

Brief Summary

The main objective of this study is to evaluate whether acceptance (measured by the AAQ-II questionnaire) is prognostic of algo-functional changes measured by the Oswestry Disability Index, ODI) at 6 months.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2017

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 20, 2015

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 27, 2015

Completed
1.9 years until next milestone

Study Start

First participant enrolled

April 3, 2017

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 8, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 8, 2019

Completed
Last Updated

October 24, 2019

Status Verified

October 1, 2019

Enrollment Period

2 years

First QC Date

April 20, 2015

Last Update Submit

October 23, 2019

Conditions

Outcome Measures

Primary Outcomes (2)

  • Classification of the patient as a responder or a non responder

    The response to treatment will be evaluated by the ODI (Oswestry Disability Index) at 6 months: a patient will be considered as a responder when the absolute change between the score at 6 months and inclusion is at least 10 points (Ostelo RW et al., 2008). This outcome is a qualitative variable with two options: responder or non-responder. The fact that we define in an apriori fashion who is a responder or not does not mean that we have created multiple outcomes. This is a single outcome.

    6 months

  • Acceptation and Action Questionnaire - II (AAQ-II) score

    Day -7 (inclusion)

Secondary Outcomes (44)

  • the AAQ-II Score

    Day 0

  • the AAQ-II Score

    Month 1

  • the AAQ-II Score

    Month 3

  • the AAQ-II Score

    Month 6

  • Oswestry Disability Index

    Day -7

  • +39 more secondary outcomes

Study Arms (1)

Lumbar spine pain inpatients

The study population corresponds to inpatient rehabilitative care for lumbar spine pain in the Departments of Physical Medicine and Functional Rehabilitation at the Nîmes and Montpellier University Hospitals.

Eligibility Criteria

Age18 Years - 74 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population corresponds to inpatient rehabilitative care for lumbar spine pain in the Departments of Physical Medicine and Functional Rehabilitation at the Nîmes and Montpellier University Hospitals.

You may qualify if:

  • The patient has been informed about the study, and is not opposed to the study
  • The patient must be insured or beneficiary of a health insurance plan
  • The patient is available for 6 month of follow-up
  • The subject has chronic back pain that is not post-operative in nature and that has lasted for more than 3 months
  • The subject accepts the re-education curriculum.

You may not qualify if:

  • The patient is participating in another study
  • The patient is under judicial protection, under tutorship or curatorship
  • The patient refuses to participate
  • It is impossible to correctly inform the patient
  • The patient is pregnant, parturient, or breastfeeding
  • The subject has a history of chronic obstructive pulmonary disease, cardiovascular disease, rheumatoid arthritis, lupus, spondylitis or neoplastic disease.
  • Patient currently under psychological treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

CHRU de Montpellier - Hôpital Lapeyronie

Montpellier, 34295, France

Location

CHRU de Nîmes - Hôpital Universitaire Carémeau

Nîmes, 30029, France

Location

MeSH Terms

Conditions

Low Back Pain

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Arnaud Dupeyron, MD, PhD

    Centre Hospitalier Universitaire de Nîmes

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 20, 2015

First Posted

April 27, 2015

Study Start

April 3, 2017

Primary Completion

April 8, 2019

Study Completion

April 8, 2019

Last Updated

October 24, 2019

Record last verified: 2019-10

Locations